Ticker Symbol | Entity Name | Employer Id | As Of Date | Profile Url | Name | Website | Company Type | Industry | Active Status | Employer Status | Headquarters City | Year Founded | Rating: Overall | Rating: CEO (%) | Rating: Business Outlook (%) | Rating: Recommend (%) | Rating: Compensation & Benefits | Rating: Culture & Values | Rating: Career Opportunities | Rating: Diversity and Inclusion | Rating: Work/Life Balance | Rating: Senior Management | Ratings Star 1 Count | Ratings Star 2 Count | Ratings Star 3 Count | Ratings Star 4 Count | Ratings Star 5 Count | Ratings Count | Ratings Diversity and Inclusion Count | Ratings CEO Count | Ratings Star 1 (%) | Ratings Star 2 (%) | Ratings Star 3 (%) | Ratings Star 4 (%) | Ratings Star 5 (%) | Awards Count | Job Count | Review Count | Interview Experience: Positive | Interview Experience: Neutral | Interview Experience: Negative | Interview Channel: Online (%) | Interview Channel: Campus Recruiting | Interview Channel: Recruiter | Interview Channel: Employee Referral | Interview Channel: Staffing Agency | Interview Channel: In-Person | Interview Channel: Other | CEO Profile Image | CEO | Date Added | Date Updated | Company Name | Sector | Industry | CEO Gender | CEO Ethnicity |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:kpti | https://www.glassdoor.com?employer_id=1390191 | 1390191 | Apr 28th, 2024 12:00AM | Open | Karyopharm Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Newton, MA | 3.80 | 85% | 65% | 72% | 4.10 | 3.60 | 3.70 | 4.00 | 3.70 | 3.60 | 6.00 | 1.00 | 3.00 | 12.00 | 23.00 | 45.00 | 63.00 | 36.00 | 13.333% | 2.222% | 6.667% | 26.667% | 51.111% | 16.00 | 145.00 | 0.47 | 0.12 | 0.41 | 0.71 | 0.14 | 0.14 | Open | Richard Paulson | Apr 28th, 2024 04:17PM | Apr 28th, 2024 04:17PM | Karyopharm Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||||||||||
nasdaq:kpti | https://www.glassdoor.com?employer_id=1390191 | 1390191 | Apr 26th, 2024 12:00AM | Open | Karyopharm Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Newton, MA | 3.80 | 85% | 65% | 72% | 4.10 | 3.60 | 3.70 | 4.00 | 3.70 | 3.60 | 6.00 | 1.00 | 3.00 | 12.00 | 23.00 | 45.00 | 63.00 | 36.00 | 13.333% | 2.222% | 6.667% | 26.667% | 51.111% | 16.00 | 145.00 | 0.47 | 0.12 | 0.41 | 0.71 | 0.14 | 0.14 | Open | Richard Paulson | Apr 26th, 2024 08:03AM | Apr 26th, 2024 08:03AM | Karyopharm Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||||||||||
nasdaq:kpti | https://www.glassdoor.com?employer_id=1390191 | 1390191 | Apr 25th, 2024 12:00AM | Open | Karyopharm Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Newton, MA | 3.80 | 85% | 65% | 72% | 4.10 | 3.60 | 3.70 | 4.00 | 3.70 | 3.60 | 6.00 | 1.00 | 3.00 | 12.00 | 23.00 | 45.00 | 63.00 | 36.00 | 13.333% | 2.222% | 6.667% | 26.667% | 51.111% | 16.00 | 145.00 | 0.47 | 0.12 | 0.41 | 0.71 | 0.14 | 0.14 | Open | Richard Paulson | Apr 25th, 2024 06:24PM | Apr 25th, 2024 06:24PM | Karyopharm Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||||||||||
nasdaq:kpti | https://www.glassdoor.com?employer_id=1390191 | 1390191 | Apr 24th, 2024 12:00AM | Open | Karyopharm Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Newton, MA | 3.80 | 85% | 65% | 72% | 4.10 | 3.60 | 3.70 | 4.00 | 3.70 | 3.60 | 6.00 | 1.00 | 3.00 | 12.00 | 23.00 | 45.00 | 63.00 | 36.00 | 13.333% | 2.222% | 6.667% | 26.667% | 51.111% | 16.00 | 7.00 | 145.00 | 0.47 | 0.12 | 0.41 | 0.71 | 0.14 | 0.14 | Open | Richard Paulson | Apr 24th, 2024 10:48AM | Apr 24th, 2024 10:48AM | Karyopharm Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |||||||||
nasdaq:kpti | https://www.glassdoor.com?employer_id=1390191 | 1390191 | Apr 23rd, 2024 12:00AM | Open | Karyopharm Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Newton, MA | 3.80 | 85% | 65% | 72% | 4.10 | 3.60 | 3.70 | 4.00 | 3.70 | 3.60 | 6.00 | 1.00 | 3.00 | 12.00 | 23.00 | 45.00 | 63.00 | 36.00 | 13.333% | 2.222% | 6.667% | 26.667% | 51.111% | 16.00 | 145.00 | 0.47 | 0.12 | 0.41 | 0.71 | 0.14 | 0.14 | Open | Richard Paulson | Apr 23rd, 2024 04:22PM | Apr 23rd, 2024 04:22PM | Karyopharm Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||||||||||
nasdaq:kpti | https://www.glassdoor.com?employer_id=1390191 | 1390191 | Apr 21st, 2024 12:00AM | Open | Karyopharm Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Newton, MA | 3.80 | 85% | 65% | 72% | 4.10 | 3.60 | 3.70 | 4.00 | 3.70 | 3.60 | 6.00 | 1.00 | 2.00 | 12.00 | 23.00 | 44.00 | 63.00 | 36.00 | 13.636% | 2.273% | 4.545% | 27.273% | 52.273% | 16.00 | 7.00 | 144.00 | 0.47 | 0.12 | 0.41 | 0.71 | 0.14 | 0.14 | Open | Richard Paulson | Apr 21st, 2024 04:23PM | Apr 21st, 2024 04:23PM | Karyopharm Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |||||||||
nasdaq:kpti | https://www.glassdoor.com?employer_id=1390191 | 1390191 | Apr 20th, 2024 12:00AM | Open | Karyopharm Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Newton, MA | 3.80 | 85% | 65% | 72% | 4.10 | 3.60 | 3.70 | 4.00 | 3.70 | 3.60 | 6.00 | 1.00 | 2.00 | 12.00 | 23.00 | 44.00 | 63.00 | 36.00 | 13.636% | 2.273% | 4.545% | 27.273% | 52.273% | 16.00 | 144.00 | 0.47 | 0.12 | 0.41 | 0.71 | 0.14 | 0.14 | Open | Richard Paulson | Apr 20th, 2024 04:39PM | Apr 20th, 2024 04:39PM | Karyopharm Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||||||||||
nasdaq:kpti | https://www.glassdoor.com?employer_id=1390191 | 1390191 | Apr 19th, 2024 12:00AM | Open | Karyopharm Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Newton, MA | 3.80 | 85% | 65% | 72% | 4.10 | 3.60 | 3.70 | 4.00 | 3.70 | 3.60 | 6.00 | 1.00 | 2.00 | 12.00 | 23.00 | 44.00 | 63.00 | 36.00 | 13.636% | 2.273% | 4.545% | 27.273% | 52.273% | 16.00 | 144.00 | 0.47 | 0.12 | 0.41 | 0.71 | 0.14 | 0.14 | Open | Richard Paulson | Apr 19th, 2024 07:36AM | Apr 19th, 2024 07:36AM | Karyopharm Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||||||||||
nasdaq:kpti | https://www.glassdoor.com?employer_id=1390191 | 1390191 | Apr 18th, 2024 12:00AM | Open | Karyopharm Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Newton, MA | 3.80 | 85% | 65% | 72% | 4.10 | 3.60 | 3.70 | 4.00 | 3.70 | 3.60 | 6.00 | 1.00 | 2.00 | 12.00 | 23.00 | 44.00 | 63.00 | 36.00 | 13.636% | 2.273% | 4.545% | 27.273% | 52.273% | 16.00 | 6.00 | 144.00 | 0.47 | 0.12 | 0.41 | 0.71 | 0.14 | 0.14 | Open | Richard Paulson | Apr 18th, 2024 05:58PM | Apr 18th, 2024 05:58PM | Karyopharm Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |||||||||
nasdaq:kpti | https://www.glassdoor.com?employer_id=1390191 | 1390191 | Apr 17th, 2024 12:00AM | Open | Karyopharm Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Newton, MA | 3.80 | 85% | 65% | 72% | 4.10 | 3.60 | 3.70 | 4.00 | 3.70 | 3.60 | 6.00 | 1.00 | 2.00 | 12.00 | 23.00 | 44.00 | 63.00 | 36.00 | 13.636% | 2.273% | 4.545% | 27.273% | 52.273% | 16.00 | 144.00 | 0.47 | 0.12 | 0.41 | 0.71 | 0.14 | 0.14 | Open | Richard Paulson | Apr 17th, 2024 02:25PM | Apr 17th, 2024 02:25PM | Karyopharm Therapeutics | Health Care | Pharmaceuticals & Biotechnology |